Stelis
  • About Us
  • Capabilities
    • Services
      • Process Development and Tech Transfer
      • cGMP Manufacturing
      • Quality Management System
    • Facilities
      • Unit 1 – Bangalore, India
      • Unit 2 – Bangalore, India
      • Unit 3 – Bangalore, India
    • Capacities
      • Drug Substance Capacities
      • Drug Product Capacities
  • Resources
    • Insights
    • Virtual Tour
    • Events
    • Corporate Governance
  • Careers
    • Working at Stelis
    • Current Opportunities
  • Contact
  • LinkedIn
  • Twitter
  • Facebook

Project

  • Show All
  • News
  • Thought Leadership
  • Fact Sheets
Stelis December Post-02 (1)
News

Stelis Biopharma’s CDMO partner receives approval for a key ANDA from the USFDA

Stelis Biopharma is pleased to announce that its CDMO partner has received ap

View Detail
Stelis_FDA_Banner1
News

Stelis’ flagship facility receives Establishment Inspection Report from USFDA for Drug Product Manufacturing

Stelis Biopharma Limited, the biologics arm of Strides Pharma Science Limited

View Detail
Facility
News

Stelis Biopharma receives EU-GMP certification for two of its manufacturing facilities

Stelis Biopharma, the biologics arm of Strides Pharma Science announced that

View Detail
Stelis Next Phase
Thought Leadership

COVID impact report 

January 2021 In 2020 the Coronavirus pandemic has, unsurprisingly, proved to

View Detail
i-picked hack of a time
Thought Leadership

I Picked A Heck Of A Time

A new CEO’s observations on managing a fast-growing, fully integrated biophar

View Detail
Unit 2 Bangalore
News

Stelis starts next phase of investment into its biologics manufacturing facility

This phase sees the CDMO start work on installing two 2,000-L single-use bior

View Detail
south-bangalore-1
Fact Sheets

Unit 1 – Bangalore, India

State-of-the-art process and analytical development facilities for small-scal

View Detail
north-bangalore
Fact Sheets

Unit 2 – Bangalore, India

Integrated state-of-the-art manufacturing facility leverages microbial and ma

View Detail
Unit-3 Bangalore
Fact Sheets

Unit 3 – Bangalore, India

A multipurpose facility with an ability to cater to multiple vaccine types in

View Detail
Outsourcing Formulation
Thought Leadership

Meeting Demand for Biologics & Specialty Drugs

A company that provides insurance and investment-related products and service

View Detail
1 2 Next Page

Stelis Biopharma
Your trusted CDMO partner

Partner with us
  • Capabilities
    • Capacities
    • Facilities
    • Site Visits
  • About Us
    • Careers
    • Contact
    • Sitemap
  • Follow Us
    • LinkedIn
    • Twitter
    • Facebook

Mail: info@stelis.com
Phone: +91-80678 40444

Subscribe to our newsletter to receive press releases, insights and other information concerning Stelis Biopharma.

Copyright © 2022 Stelis
  • About Us
  • Capabilities
    • Services
      • Process Development and Tech Transfer
      • cGMP Manufacturing
      • Quality Management System
    • Facilities
      • Unit 1 – Bangalore, India
      • Unit 2 – Bangalore, India
      • Unit 3 – Bangalore, India
    • Capacities
      • Drug Substance Capacities
      • Drug Product Capacities
  • Resources
    • Insights
    • Virtual Tour
    • Events
    • Corporate Governance
  • Careers
    • Working at Stelis
    • Current Opportunities
  • Contact
  • LinkedIn
  • Twitter
  • Facebook









    captcha









      captcha